AstraZeneca bladder cancer therapy wins NICE backing - PharmaTimes Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease

#AstraZeneca #bladdercancer #NICE #NICErecommended #durvalumab #perioperativeIOtreatment #perioperativeimmuneoncologytreatment #muscleinvasivebladdercancer #Niagaraphase3trial #bladdercancerpatients #innovativemedicine #JeannieRigby #bladdercancercare #perioperativeDurvalumab
zurl.co/U8lNl

🎖️ ABC UK Nurse of the Year Award 2025 🎖️

Let’s celebrate those making a difference in bladder cancer care. Nominate your brilliant colleague today! 💙
actionbladdercanceruk.org/nurse-of-the...

#ABCUK #NurseOfTheYear #BladderCancerCare #NurseRecognition #SpecialistNurse

VI-RADS Scores for Muscle-Invasive Bladder Cancer - OncoDaily VI-RADS Scores for Muscle-Invasive Bladder Cancer / bladder cancer, bladder cancer care, bladder cancer research, cancer, Cancer diagnostics, cancer outcomes,

VI-RADS Scores for Muscle-Invasive Bladder Cancer

oncodaily.com/blog/236075

#BladderCancer #BladderCancerCare #CancerDiagnostics #Immunotherapy #MRITechnology #MultiparametricMRI #NeoadjuvantChemotherapy #OncoDaily #Oncology #Medicine #Health #OncologyAdvancements #OncologyBiomarkers